Mike Catton

4.6k total citations · 1 hit paper
34 papers, 2.5k citations indexed

About

Mike Catton is a scholar working on Infectious Diseases, Epidemiology and Biomedical Engineering. According to data from OpenAlex, Mike Catton has authored 34 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 11 papers in Epidemiology and 5 papers in Biomedical Engineering. Recurrent topics in Mike Catton's work include SARS-CoV-2 and COVID-19 Research (12 papers), SARS-CoV-2 detection and testing (8 papers) and Virology and Viral Diseases (6 papers). Mike Catton is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), SARS-CoV-2 detection and testing (8 papers) and Virology and Viral Diseases (6 papers). Mike Catton collaborates with scholars based in Australia, Singapore and United States. Mike Catton's co-authors include Julian Druce, Leon Caly, Kylie M. Wagstaff, David A. Jans, Chris Birch, J Leydon, Doris Chibo, Thomas Tran, Nicole M. Isbel and G J Becker and has published in prestigious journals such as Journal of Virology, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Mike Catton

34 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

2020 1.5k citations Leon Caly, Julian Druce et al. Antiviral Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mike Catton Australia	17	1.8k	422	319	278	187	34	2.5k
Leon Caly Australia	15	1.8k 1.0×	402 1.0×	320 1.0×	493 1.8×	195 1.0×	31	2.6k
Naganori Nao Japan	19	1.7k 1.0×	546 1.3×	209 0.7×	296 1.1×	82 0.4×	41	2.2k
Satoshi Kutsuna Japan	23	1.9k 1.1×	465 1.1×	353 1.1×	330 1.2×	61 0.3×	191	3.1k
Michael Letko United States	17	2.6k 1.5×	402 1.0×	379 1.2×	534 1.9×	161 0.9×	33	3.3k
Martin J. Vincent United States	20	2.9k 1.7×	385 0.9×	296 0.9×	398 1.4×	157 0.8×	22	3.5k
Catharine I. Paules United States	16	1.5k 0.9×	1.3k 3.0×	288 0.9×	452 1.6×	100 0.5×	28	3.4k
Reed F. Johnson United States	29	2.1k 1.2×	778 1.8×	180 0.6×	628 2.3×	198 1.1×	85	3.2k
Huahao Fan China	24	877 0.5×	269 0.6×	149 0.5×	698 2.5×	138 0.7×	114	2.2k
Yao Deng China	29	1.5k 0.9×	530 1.3×	129 0.4×	548 2.0×	91 0.5×	131	3.0k
Marilda Mendonça Siqueira Brazil	31	1.4k 0.8×	2.0k 4.6×	285 0.9×	308 1.1×	65 0.3×	183	3.3k

Countries citing papers authored by Mike Catton

Since Specialization

Citations

This map shows the geographic impact of Mike Catton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Catton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Catton more than expected).

Fields of papers citing papers by Mike Catton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Catton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Catton. The network helps show where Mike Catton may publish in the future.

Co-authorship network of co-authors of Mike Catton

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Catton. A scholar is included among the top collaborators of Mike Catton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Catton. Mike Catton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nicholson, Suellen, Theo Karapanagiotidis, Arseniy Khvorov, et al.. (2021). Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance. Open Forum Infectious Diseases. 8(7). ofab239–ofab239. 15 indexed citations

Gregory, Gareth P., Anna Pierce, Julian Druce, et al.. (2021). Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient. Infection Control and Hospital Epidemiology. 43(6). 820–822. 4 indexed citations

Franklin, Lucinda, Suellen Nicholson, Francesca L. Mordant, et al.. (2021). Symptoms and laboratory manifestations of mild COVID-19 in a repatriated cruise ship cohort. Epidemiology and Infection. 149. e44–e44. 10 indexed citations

Graham, Maryza, Susan A. Ballard, Shivani Pasricha, et al.. (2021). Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global experience in an Australian context. Pathology. 53(6). 689–699. 10 indexed citations

Bond, Katherine, Suellen Nicholson, Seok Lim, et al.. (2020). Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting. The Journal of Infectious Diseases. 222(8). 1280–1288. 38 indexed citations

Williams, Eloise, Katherine Bond, Yano Yoga, et al.. (2020). Detection of SARS-CoV-2 in saliva: implications for specimen transport and storage. Journal of Medical Microbiology. 70(2). 21 indexed citations

Williams, Eloise, Katherine Bond, Julian Druce, et al.. (2020). Pandemic printing: Evaluation of a novel 3D printed swab for detection of SARS-CoV-2. The Medical Journal of Australia. 1. 1 indexed citations

Graham, Maryza, Eloise Williams, Julian Druce, et al.. (2020). Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay. Diagnostic Microbiology and Infectious Disease. 99(2). 115238–115238. 11 indexed citations

Williams, Eloise, Katherine Bond, Douglas Johnson, et al.. (2020). Pandemic printing: a novel 3D‐printed swab for detecting SARS ‐CoV‐2. The Medical Journal of Australia. 213(6). 276–279. 27 indexed citations

10.

Caly, Leon, Julian Druce, Mike Catton, David A. Jans, & Kylie M. Wagstaff. (2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research. 178. 104787–104787. 1478 indexed citations breakdown →

11.

Williams, Eloise, Katherine Bond, Peter Kyriakou, et al.. (2020). Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory. Pathology. 52(7). 754–759. 6 indexed citations

12.

Catton, Mike, Glenda Gray, Diane E. Griffin, et al.. (2018). 2017 international meeting of the Global Virus Network. Antiviral Research. 153. 60–69. 3 indexed citations

13.

Leydon, Jennie, Michaela A. Riddell, Hazel J Clothier, et al.. (2011). Evaluation of the World Health Organization Global Measles and Rubella Quality Assurance Program, 2001–2008. The Journal of Infectious Diseases. 204(suppl_1). S499–S505. 7 indexed citations

14.

Catton, Mike, et al.. (2009). The efficacy of complementary and alternative medicine in the treatment of Raynaud's phenomenon: a literature review and meta-analysis. Lara D. Veeken. 48(7). 791–795. 30 indexed citations

15.

Kumar, Purnima, Vithiagaran Gunalan, Bo Liu, et al.. (2007). The nonstructural protein 8 (nsp8) of the SARS coronavirus interacts with its ORF6 accessory protein. Virology. 366(2). 293–303. 45 indexed citations

16.

Tan, Timothy H. P., Vithiagaran Gunalan, Julian Druce, et al.. (2007). Induction of Apoptosis by the Severe Acute Respiratory Syndrome Coronavirus 7a Protein Is Dependent on Its Interaction with the Bcl-X _L Protein. Journal of Virology. 81(12). 6346–6355. 105 indexed citations

17.

Guy, Rebecca, et al.. (2005). Improving HIV Surveillance in Victoria. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(4). 495–499. 9 indexed citations

18.

Catton, Mike. (2005). US health spending up; medicare expanded. Canadian Medical Association Journal. 172(12). 1545–1545. 2 indexed citations

19.

Guy, Rebecca, Ross Andrews, H Kelly, et al.. (2004). Mumps and rubella: a year of enhanced surveillance and laboratory testing. Epidemiology and Infection. 132(3). 391–398. 19 indexed citations

20.

Smith, Kenneth G. C., et al.. (1998). Suppression of the humoral immune response by mycophenolate mofetil. Nephrology Dialysis Transplantation. 13(1). 160–164. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact